Abstract To understand the molecular mechanisms of cellular stgnalmg of atria1 natrmrettc pepttde (ANP), we have studied Its effect on the enzymatrc activrty of endogenous and overexpressed protein kmase C (PKC) m rat thoracrc aortrc vascular smooth muscle (RTASM) cells Angrotensm II (ANG II), endothelm-1 (ET-l), and 12-O-tetradecanoylphorbol 13-acetate (TPA) stimulated fourfold to fivefold PKC acttvny m PKC-a cDNA-transfected RTASM cells However, pretreatment of these cells with ANP significantly mhlbtted the agonist-stimulated PKC actlvrty m a dose-dependent manner The mhtbltory effect of ANP was more effective If cells were transfected wrth both PKC-a and guanylyl cyclase-A/atria1 natrmrettc pepttde receptor (Npra) cDNAs The agomst-strmulated PKC actrvrty was also mhrbtted rf RTASM cells were pretreated with cGMP analog 8-bromo-cGMP, however, the treatment of cells with a CAMP analog, dtbutyryl-CAMP, did not show any dtscermble effect The pretreatment of cells with Npra antagonist A-71915, srgmficantly blocked the productron of cGMP as well as the mhtbttory effect A trial natrmretic peptide is an endogenous and potent hypotensive hormone that regulates sodmm excretion, water balance, steroidogenesis, and cell proliferation. l-4 One of the prmcipal components mvolved m the regulatory action of ANP is the guanylyl cyclase-linked atria1 natriuretic peptide receptor (GC-A), also designated as Npra.5 Natnuretic peptide receptor/ guanylyl cyclase-A is a unique class of cell surface receptors that contam an extracellular hgand-bmdmg domain, a single transmembrane spanning region and mtracellular protein kmase-hke and guanylyl cyclase catalytic domains that synthesizes the intracellular second messenger cGMP m response to ANP bmdmg.6*7 In addition to Npra, another natrmretic peptide receptor with guanylyl cyclase activity (GC-B) has been cloned and designated as Nprb.5 The evidence suggests that both ANP and BNP selectively bmd to Npra, and CNP has been shown pnmanly to bmd Nprb. 899 However, all three natriuretic peptides (ANP, BNP, and CNP) mdiscnmmately bmd to naProm the Department of Brochemistry and Molecular Brology (R K , W A C , K N P ), Medical College of Georgra, School of Medacme, Augusta, and the Department of Pathology (T M L ), Umversrty of Alabama at Brrmmgham Correspondence to Dr Karlash N Pandey, Department of BIOchemistry and Molecular Biology, Medrcal College of Georgia School of Medrcme, Augusta, GA 30912-2100 0 1997 Amerrcan Heart Assocratron, Inc of ANP on PKC actrvrty. To further examme whether the antagomsttc action of ANP and 8-bromo-cGMP on agonist-sttmulated PKC activity were mediated through cGMP-dependent protein kmase (PKG), cells were treated wrth ANP or 8-bromo-cGMP and activators of PKC m the presence of KT-5823, a specrfic mhlbrtor of PKG The treatment of cells with KT-5823 slgmficantly attenuated the mhtbttory effects of both ANP and 8-bromocGMP on agonist-stimulated PKC actrvrty The results from these studies provide strong evidence that ANP antagonizes the activation of PKC m RTASM cells, mvolvmg guanylyl cyclase-A receptor Npra and second messenger cGMP Our data further support the notion that ANP acts as a negative mediator of stgnalmg cross-talks between Npra and PKC m a cGMP-dependent manner, probably mvolvmg cGMP-dependent protem kmase tn this process (Hypertension. 1997;29[part 2]:414-421.) Key Words 9 atria1 natnuretm pepttde l guanylyl cyclase receptor-A l protein kmase C l cGMP l angtotensm II l phorbol ester l vascular smooth muscle cells trmretic peptide-clearance receptor (Nprc), which has been suggested to clear natriuretic peptides from the cnculation.10 Although vascular smooth muscle cells predommantly contam Nprc, ii all three natrmretic peptides (ANP, BNP, and CNP) produce increased levels of mtracellular cGMP m these cells i2-i5 Hitherto, the signaling mechanisms of natrruretrc peptrdes in vascular smooth muscle cells are relatively complex and only poorly understood Vascular hypertrophy and increased growth is a characteristic response of the terminally differentiated vascular smooth muscle cells to growth stimuh m vitro 16-18 This is characterized by an increase m protein synthesis and also by load-specific changes in the pattern of gene expression m vtvo that can be recapitulated m cultured cells subjected to growth-stimulatory agents in vitro. 19 A cascade of the mtracellular signaling processes, largely identified m vascular smooth muscle cells, has been proposed to mediate the adaptive response of these cells, a central component of which 1s the activation of calcmmdependent isoforms of PKC Whether this signaling cascade triggers an adaptive vascular smooth muscle cell hypertrophy and/or normal cellular growth m viva m still unclear Previously, Npra has been shown to interact with PKC2OJi, however, the exact mechanisms of these mteractions have not been clearly elucidated Accordmgly, using rat vascular smooth muscle cells as a model system, Cell Cultures RTASM cell culture was established essentially as previously descnbed.*z Cells were cultured in Dulbecco's modified Eagle's me&urn (DMEM) contammg 10% (vol/vol) fetal calf serum All cultures were maintained at 37°C m an atmosphere of 5% CO2 and 95% O2 Cultures were fed on alternate days and were subcultured every 6 days Plasmid Construction A full-length cDNA coding the PKC-(Y was removed from the plasmid Bluescnpt by EcoRI digestion and subcloned mto the previously EcoRI-chgested site of the mammalian expressIon vector pcDNA3 (Invitrogen) A complete Npra cDNA codmg sequence was removed from Bluescript by Not I dlgeshon and was subcloned mto the previously Not I-digested pcDNA3 vector m which the expression IS denved from the cytomegalovuus with SV-40 origin of replication.
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Transfection
RTASM cells were electroporated with 15 to 25 pg circular plasmid DNA at 220 volts with a capacitance setting of 960 /IF using a Gene Pulser @oRad), according to the manufacturer's protocol. After electroporation, cells were seeded mto 60-mm culture dishes containing DMEM with 10% bovine fetal calf serum The medium was changed after 24 hours of transfection The efficiency and reproducibility of transfection were examined with the P-X-gal method according to MacGregor 23 Cells were washed with Ca2+/MgZf-free PBS and fixed m 1% vol/vol formanude m PBS for 30 mmutes, after wluch cells were rinsed twice with PBS and stained overnight at room temperature m a solution containing 1 X PBS, 0 004 mol/L ferrocyamde, 0 004 mol/L fencyanide, 0 002 mol/L M&l*, and 500 pg/mL X-gal. Transfection efficiency was quantitated with microscopic mspectlon of stained cells
Hormonal Treatment
All treatments were done m culture medmm contammg 0 1% BSA without serum with vehicular control as DMSO After 48 hours of transfectlon, cells were treated with several concentrations of TPA (a potent PKC activator) and vasoconstrictors ANG II and ET-l Cells were pretreated with ANP, 8-bromo-cGMP, Npra mlnbitor A-71915, which blocks the production of cGMP m response to ANP, KT-5823, a specrlic mhlbltor of cGMP-dependent protein kmase, and staurosponne, which 1s a potent calcium-dependent PKC mlubitor All treatments were done for 15 minutes unless otherwise Indicated
Preparation of Whole Cell Extracts
Cells were washed twice with PBS and then with 0 01 mol/L Tns-HCl, pH 7.5. The cells were scraped m buffer A containing Tris-HCl (0 02 mom, pH 7 5), EDTA (0 005 mol/L), EGTA (0 01 mol/L), P-mercaptoethanol (0 05 mol/L), Triton X-100 (0 5%), leupeptm (5 pg/mL), aprotmm (5 PglmL), and PMSF (50 pg/mL) Cells were homogenized by 50 strokes with a dounce homogenizer and incubated for 30 mmutes on ice The homogenate was centrifuged at 12 000~ for 15 minutes The supernatant was loaded onto a 0 5 mL DEAE-Sephacel column preeqmhbrated with buffer A The column was washed with 10 volumes of buffer A contammg 0 03 mol/L NaC 1 The PKC fractions were eluted with buffer A containing 0 2 mol/L NaCl Assay of PKC Activity PKC activity was determined using the EGF-R peptide VRKRTLRRL, a specific PKC substrate as described previously 24 The reaction mixture contained 20 to 25 PL partially purified column eluate, 8 mole percent L-phosphatidyl-L-serme, 0 0025 mol/L DTT, 0 001 mol/L calcium acetate, 9X10-" moVL EGF-R peptIde substrate, 0 0 15 mol/L magnesium acetate, 5X10m7 moln ATP, and 1 X lo-" mol C@*P]ATP and incubated at 25°C for 15 minutes The reaction was stopped by addmg 100 PL of 30% (vol/vol) acetic acid An ahquot (125 pL) was removed from the reaction mixture and applied to p81 phosphocellulose paper After two washes with 5% acetic acid, the papers were dned and bound radIoactivity was determined by scintillation counting The specific activity of PKC IS expressed as picomoles 32P transferred per mdhgram substrate protem per tnmute Total protein was estimated with the BIoRad protein assay leagent kit, using BSA as a standard
Western Blotting
For immunological detection of cGMP-dependent protein klnase-la, samples were prepared accordmg Keilback et al z Confuent RTASM cells were washed twice with Ice-cold PBS and scraped m a buffer contammg; 0 0081 mol/L NaHPO,, 0 0018 mol/L KHZ PO.,, pH 7 2, 0 137 mol/L NaCl, and 0 0027 mol/L KC1 After centnfugation, cell pellets were suspended m a solution contammg 0 02 mol/L K2HP04, pH 7 0,O 002 mol/L EDTA, and 0 002 mol/L benzanmhne After freezmg and thawing, the cell suspension was homogenized with a Teflon-glass homogenizer and centrifuged at 15 OOOg for 30 minutes at 4°C Proteins from the supernatant were electrophoresed on a 7 5% SDS-polyacrylanude gel, accordmg to Laemmh,*G and blotted onto Immobilon P membrane (Milhpore) by the method of Towbm et al 27 Nonspecific sites were blocked by overnight mcubatlon of membrane m 5% nonfat dry milk m PBS, pH 7 5, containing 0 1% Tween 20 Membranes were Incubated with specific polyclonal antiboches of PKG-la (1.400 dilution) for 2 to 3 hours and then washed three times (10 mmutes each wash) with PBS/ Tween 20 The bmclmg of primary antibody was detected with a horseradish peroxidase conjugated secondary antibody and an enhanced chenulummescence Western blottmg detection system (Amersham) Antibodies against bovine cGMP-dependent protein kmase were produced as described previously ** These antibodies at dilutions between 1 50 and I 1000 reacted with one protein on Western blots and were identified as the cGMP-dependent protem kmase with molecular mass of 70 kD At lower dilutions, the antiserum was able to react with a 40 kD protein which was 
RNA Isolation and Northern Analysis
Total RNA was isolated form RTASM cells by a modlficatlon of the guamdmmm lsotlnocyanate method, according to Chomczynsla and Sacchl.*9 Total RNA (20 pg) from RTASM cells was resolved by a 1% denaturing formaldehyde agarose gel and transferred onto a nylon membrane (Duralon membrane, Stratagene) by a pressure blotter, accorchng to the manufacturer's protocol The membranes were fixed by UV crosslmkmg using Stratalmker (Stratagene). Rlbosomal RNA on the membrane was stained with methylene blue to detect potential dtfferences m loading and/or transfer efficlencles Prehybndlzatlon and hybndlzatlon were done at 42"C m solution contammg 50% deionized formamlde, 5X SSC, 5X Denhardt's solution, 1% SDS, and 100 ,ug/mL denatured salmon sperm DNA added only mto prehybndrzatton solution. The membrane was hybrldlzed with a 1 2-kb EcoRI restrictlon fragment of murme Npra cDNA,7 which was labeled with [(r-32P]dCTP by a random pnmer ohgolabelmg kit (Pharmacla) The membrane was washed twice with 2X SSC/ 0 1% SDS at room temperature for 15 minutes and once with O.OlxSSC/O 1% SDS at 65°C for 15 minutes. RNA bands contaming Npra mRNA homology were made visible by exposing Kodak X-Omat AR film to the washed membrane at -80°C with mtenslfying screen. (Fig 2) On the other hand, if cells were transfected with PKC-a cDNA, and then treated with ANP and TPA, an approxlmately 35% mhlbltlon m PKC activity was observed The TPA concentration of 0.1 mol/L was required to reach an apparent plateau of PKC activation (data not shown) A more detailed time course of the effect of 0.1 mol/L TPA showed that the activation time of PKC required to reach a maximum stlmulatory level was 15 minutes, after which PKC activity was downregulated (Fig 3) RTASM cells were cotransfected with PKC-(w and Npra cDNAs to examme the effect of ANP on TPA-stimulated and overexpressed PKC actlvlty m these cells In the cotransfected RTASM cells, TPA (0 1 mol/L) stimulated the PKC actlvlty by more than fourfold and pretreatment with ANP (0 1 mom) inhibited the agonist-stimulated PKC activity by more than 65% (Fig 4) . The overexpresslon of PKC was confirmed by the Western blot analysis usmg the polyclonal antibodies against PKC-(Y whtch indicated an approximately 2.5fold greater PKC lmmunoreactlvlty m PKC-(r cDNA-transfected cells than m nontransfected cells (data not shown) The overexpression of Npra m RTASM cells was examined by quantitatmg the levels of Npra mRNA in transfected and control cells Northern blot analysis revealed that Npra mRNA was expressed, approximately at a 2 S-fold to 3-fold higher level m the cDNA-transfected cells than in cells transfected with vector alone (Fig 5) Npra in RTASM cells, the intracellular accumulation of cGMP was determined. In Npra-transfected cells, ANP induced approximately &fold to 70-fold higher cGMP production than in nontransfected or vector-transfected RTASM cells (Fig 6) .
Vasoconstrictors ANG II and ET-l also stimulated PKC activity by more than fourfold in PKC-a-transfected cells compared with the cells transfected with vector alone (Fig  7a and 7b) . The maximum stimulatory effects of ANG II and ET-1 were exhibited at 0.1 mol/L peptide concentrations in these cells. Treatment of PKC-(r-and Npra-cotransfected cells with either ANG II or ET-1 also stimulated approximately 35fold to 4-fold PKC activity; however, the pretreatment of these cells with ANP exhibited a reduction of more than 65% to 70% in ANG II-or ET-l-stimulated PKC activity (Fig 8) . Treatment of vector-trancfected RTASM cells with ANG II or ET-l resulted in an approximately 1 S-fold increase in PKC activity, and pretreatment of these cells with ANP attenuated only 18% to 20% PKC enzymatic activity. In separate experiments, we further examined whether the inhibitory effect of ANP on PKC activity was mediated through the involvement of second messenger cGMP and cGMP-dependent protein kinase (PKG) Whole cell extracts were prepared and PKC activity was determined as described in "Methods " Each data point represents the meanzSE of three to four determinations A-71915, which blocked the ANP-dependent mtracellular accumulatron of cGMP (Fig 6) Furthermore, usmg polyclonal antibodres, we detected PKG-la rmmunoreactrvrty by Western blot m RTASM cells (Fig 9) The pretreatment of cells wrth Npra antagonist A-71915 reversed the ANPdependent mhrbrtron of agonist-stimulated PKC activity (Table) Data presented in the Table further show that TPA-stimulated PKC activity m RTASM cells was also mhtbrted by 8-bromo-cGMP, which correlated with ANP effects Srmrlar concentrations of dibutyryl-CAMP were unable to inhibit the PKC activity m these cells. By exposure of both transfected and untransfected cells to KT-5823, an antagonist of cGMP-dependent protein kmase, the mhrbrtory effect of ANP on agonist-strmulated PKC activity was srgmficantly neutralized (Table) Staurosporme, a PKC antagonist, blocked the agonist-stimulated PKC activity in RTASM cells.
Discussion
The results presented herein demonstrate that ANP exerts an mhtbrtory effect on both endogenous and overexpressed PKC activity m RTASM cells ANP mhrbrted the agomst-stimulated PKC activity m both untransfected and transfected cells m a time-and dose-dependent manner, mdrcatmg that RTASM cells are responsive to ANP srgnal The mhrbrtory effect of ANP on PKC actrvrty was further increased if cells were cotransfected with PKC-a! and Npra cDNAs, suggesting that ANP effect was exerted m a receptor-mediated manner mvolvmg Npra that synthesizes mtracellular second messenger cGMP after ANP bmdmg To demonstrate whether ANP antagonized PKC activity involving Npra and its second messenger cGMP, we utrhzed Npra antagonist A-71915 and KT-5823, an mhrbrtor of cGMP-dependent protein kmase ( of these cells has not been fully resolved.1" The results obtained in the present study demonstrate that the inhibitory effect of ANP on PKC activity in RTASM cells is mediated through guanylyl cyclase-A receptor and the second messenger cGMP, which is considered an important regulator of vascular smooth muscle cell contraction.'3 It has previously been suggested that cGMP interacts with three types of intracellular receptor proteins, which may include cGMP-dependent protein kinase, cGMP-regulated ion channels, and cGMP-activated phosphodiesterases.34 It is possible that cGMP can alter cell function through various mechanisms, including stimulation of protein phosphorylation and/or by an inhibitory effect on this process. Our previous studies as well as data reported from other laboratories have shown that both ANP and cGMP inhibited the autophosphorylation and enzymatic activity of PKC in plasma membrane preparations of various target cells."5-40 Nevertheless, those previous studies on the inhibitory effects of ANP and cGMP, with regard to either autophosphorylation or the enzymatic activity of PKC, did not provide the specificity of PKC isocnzymes and the involvement of specific ANP receptor subtypes. The present results provide direct evidence that ANP exerts an inhibitory effect on the agonist-stimulated enzymatic activity of PKC in RTASM cells, involving the guanylyl cyclase-A receptor and intracellular second messenger cGMP. Although PKG is considered a major receptor for cGMP in vascular smooth muscle cells, its level is markedly decreased with culture conditions of these cells.41 Furthermore, it has been suggested that a crossover in the signaling mechanisms of CAMP and cGMP occurs in vascular smooth muscle cel1s.Q RTASM cells used in the present study contained a detectable amount of PKG-lol, and both ANP and S-bromo-cGMP inhibited the PKC activity; however, dibutyryl-CAMP did not show any discernible effect. Recently, it has been suggested that cGMPdependent signaling mechanism of Npra in vascular smooth muscle cells is probably initiated at the level of receptor gene."' Previous studies have suggested that cultured vascular smooth muscle cells predominantly contain ANP-clearance receptor (90% to 95%) and a very low level of Npra (1% to 5%). 11~2~15 Our present results demonstrate that ANP inhibited only 30% to 35% of agoniststimulated PKC activity in PKC-cu overexpressing RTASM cells. However, if cells were cotransfected with both Npra and PKC-a, the inhibitory effect of ANP was increased by more than 65% to 70%. These observations suggest that by increasing the number of guanylyl cyclaselinked receptors, the threshold effect of ANP can also be increased in vascular smooth muscle cells.
The activation of PKC has been suggested to trigger the agonist-dependent phosphorylation of many cellular proteins, causing alterations in various pathophysiological conditions; including hypertension,44-46 cardiac hypertrophy,dT ischemia,"* and atherosclerosis.49 5" PKC is a multifunctional serine/threonine kinase that is activated by Ca*+/phospholipids and phorbol esters.51.52 On the basis of molecular cloning, PKC is believed to be a multigene family, consisting of at least 12 isoenzymes that can be divided into classical, novel, and atypical forms.iJ 54 Some of these isoforms (e, 6, 7, and 4) do not require Ca*+, while other isoforms (c and t) do not require Ca*+ or diacylglycerol for activity. It is possible that seemingly opposite effects might be induced by PKC activation, which is likely due to the differential expression, activation, and translocation of a particular isoform. Agonists that activate PKC also produce two distinct second messengers, IPi, which elevates cytosolic free calcium, and diacylglycerol, which stimulates PKC enzymatic activity.52 is 56 PKC is well recognized to inhibit receptor-mediated phosphoinositol hydrolysis, IP1 formation, and subsequently intracellular calcium mobilization in a number of different cell types.57-59 Our recent studies have suggested that ANP inhibits the formation of IP1 in a cGMP-dependent manner in intact Leydig tumor (MA-IO) cells, suggesting that the inhibitory effects of ANP on PKC activity might be linked with its antagonistic action on IP? formation."0 However, further studies are warranted to support these observations in other ANP-responsive cell systems. A number of vasoactive 
